ATE338825T1 - Zellen zur produktion von helper-abhängigen adenoviren-vektoren - Google Patents

Zellen zur produktion von helper-abhängigen adenoviren-vektoren

Info

Publication number
ATE338825T1
ATE338825T1 AT99956316T AT99956316T ATE338825T1 AT E338825 T1 ATE338825 T1 AT E338825T1 AT 99956316 T AT99956316 T AT 99956316T AT 99956316 T AT99956316 T AT 99956316T AT E338825 T1 ATE338825 T1 AT E338825T1
Authority
AT
Austria
Prior art keywords
cells
genic
helper
genic unit
unit
Prior art date
Application number
AT99956316T
Other languages
German (de)
English (en)
Inventor
Stefano Colloca
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Application granted granted Critical
Publication of ATE338825T1 publication Critical patent/ATE338825T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C12N2710/10352—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99956316T 1998-11-06 1999-11-08 Zellen zur produktion von helper-abhängigen adenoviren-vektoren ATE338825T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998RM000694A IT1302403B1 (it) 1998-11-06 1998-11-06 Cellule per la produzione di vettori adenovirali difettivi, metodoper la loro preparazione e loro uso.

Publications (1)

Publication Number Publication Date
ATE338825T1 true ATE338825T1 (de) 2006-09-15

Family

ID=11406205

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99956316T ATE338825T1 (de) 1998-11-06 1999-11-08 Zellen zur produktion von helper-abhängigen adenoviren-vektoren

Country Status (9)

Country Link
US (1) US6890528B1 (https=)
EP (1) EP1127149B1 (https=)
JP (1) JP2002535961A (https=)
AT (1) ATE338825T1 (https=)
AU (1) AU768489B2 (https=)
CA (1) CA2349594C (https=)
DE (1) DE69933131T2 (https=)
IT (1) IT1302403B1 (https=)
WO (1) WO2000028060A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY139948A (en) * 2000-09-28 2009-11-30 Bayer Corp Enhanced transfection system
US7723102B2 (en) 2000-09-28 2010-05-25 Bayer Corporation Enhanced transfection system
DE602004010112T2 (de) * 2004-09-14 2008-09-18 Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) In cis regulierte konditionelle Genvektoren
GB202410992D0 (en) * 2024-07-26 2024-09-11 Icosphere Biosciences Ltd Process for making gutless helper-dependent adenoviruses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080569A (en) * 1993-06-24 2000-06-27 Merck & Co., Inc. Adenovirus vectors generated from helper viruses and helper-dependent vectors
FR2716459B1 (fr) 1994-02-22 1996-05-10 Univ Paris Curie Système hôte-vecteur utilisable en thérapie génique.
FR2738575B1 (fr) 1995-09-08 1997-10-10 Centre Nat Rech Scient Cellules pour la production d'adenovirus recombinants
SI0833934T2 (sl) * 1995-06-15 2013-04-30 Crucell Holland B.V. Pakirni sistemi za humani rekombinantni adenovirus za uporabo v genski terapiji
US6228646B1 (en) 1996-03-07 2001-05-08 The Regents Of The University Of California Helper-free, totally defective adenovirus for gene therapy
NZ334827A (en) * 1996-09-25 2001-02-23 Scripps Research Inst High-capacity adenoviral vectors suitable for adenoviral-based gene therapy
CZ156098A3 (cs) * 1996-09-26 1998-10-14 Hörmann KG Antriebstechnik Držák ozubeného kotouče pro pohony vrat
WO1999064577A1 (en) * 1998-06-09 1999-12-16 Merck & Co., Inc. Novel adenoviral vectors for gene therapy
CA2340276A1 (en) * 1998-08-28 2000-03-09 Duke University Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences

Also Published As

Publication number Publication date
DE69933131T2 (de) 2007-03-29
WO2000028060A3 (en) 2000-10-05
IT1302403B1 (it) 2000-09-05
CA2349594A1 (en) 2000-05-18
US6890528B1 (en) 2005-05-10
DE69933131D1 (de) 2006-10-19
ITRM980694A0 (it) 1998-11-06
EP1127149B1 (en) 2006-09-06
AU1294500A (en) 2000-05-29
AU768489B2 (en) 2003-12-11
EP1127149A2 (en) 2001-08-29
WO2000028060A2 (en) 2000-05-18
CA2349594C (en) 2007-02-06
ITRM980694A1 (it) 2000-05-06
JP2002535961A (ja) 2002-10-29

Similar Documents

Publication Publication Date Title
TR200003803T2 (tr) Üreme hatalı yeniden bağlayıcı mutasyonlu ana son arttırıcı
ATE282087T1 (de) Modifiziertes enzym mit lipolytischer aktivität
NZ509633A (en) A recombinant chimeric PEG-uricase with a long circulatory life and reduced immunogenicity
ATE322547T1 (de) Adenovirale vektoren für die behandlung der hämophilie
TR200000578T2 (tr) Heparanas aktiviteye sahip olan bir polipeptit deşifre eden polinükleotit ve çevrilmiş hücrelerde aynısını izahı.
WO2001086890A3 (en) A method and system for decreasing routing latency for switching platforms with variable configuration
FI971783A7 (fi) Adenoviruksia, joissa ei ole elinkykyisiä kontaminoivia partikkeleita, niiden valmistus ja käyttöjä
NZ606504A (en) Modified proteases that inhibit complement activation
NO20005613L (no) Nukleinsyremolekyler som koder for enzymer avledet fra hvete og som er involvert i syntesen av stivelse
ATE329018T1 (de) Verbesserte galactosylierung von rekombinanten proteinen
NO20012718L (no) Ekspresjonssystem for faktor VIII
DE69840948D1 (de) Invertierte terminale repeats von aav, die für die transkription aktiviert sind, zur verwendung in rekombinanten aav-vektoren
ATE338825T1 (de) Zellen zur produktion von helper-abhängigen adenoviren-vektoren
EP1282722A4 (en) STABILIZED PROTEINS
EP1218018A4 (en) USE OF COLOSTRININ, ITS PEPTIDE COMPONENTS AND ITS ANALOGS AS REGULATORS IN OXIDATIVE STRESS
ATE337953T1 (de) Steuermodul für zwei lufttrockner mit kontinuierlichem strom und steuerverfahren
ATE270709T1 (de) Methoden zum aufsuchen von modulatoren der calcineurinaktivität
NO971247L (no) Defektive, rekombinante adenoviruser med inaktivt IVa2-gen
TR199801300T2 (xx) Selülaz ve oksidoredüktaz ile muamele edilen kumaş.
ATE342998T1 (de) Replikation -defektive baculoviren expressionssystem
WO2000012741A3 (fr) Systeme d'expression inductible
DE69737457D1 (de) O-fukosyltransferase
WO1999037758A3 (en) Expression of proteolytically-sensitive peptides
DE69533626D1 (de) Tioredioxine h aus zwig und hart-weizen und ähnliche proteine, diese kodierende dna-fragmente und verfahren zu ihrer herstellung
FI972909A0 (fi) Oekad produktion av avsoendrade proteiner genom rekombinatjaestceller

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties